Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI).
Industry description
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Pharmaceuticals Select Industry Index.
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
Market Cap
The average market capitalization across the Direxion Daily Phrmctcl&MdclBl3XShrsETF ETF is 46.51B. The market cap for tickers in the group ranges from 16.65M to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is MRNS at 16.65M.
High and low price notable news
The average weekly price growth across all stocks in the Direxion Daily Phrmctcl&MdclBl3XShrsETF ETF was 9%. For the same ETF, the average monthly price growth was 28%, and the average quarterly price growth was 189%. JAZZ experienced the highest price growth at 14%, while EOLS experienced the biggest fall at -27%.
Volume
The average weekly volume growth across all stocks in the Direxion Daily Phrmctcl&MdclBl3XShrsETF ETF was -32%. For the same stocks of the ETF, the average monthly volume growth was -4% and the average quarterly volume growth was 12%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 58
P/E Growth Rating: 76
Price Growth Rating: 48
SMR Rating: 76
Profit Risk Rating: 69
Seasonality Score: 41 (-100 ... +100)